Codes / ICD10CM / E11.3393

E11.3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral

Summary

Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral, is a condition where chronic high blood sugar levels cause damage to the small blood vessels in both retinas, leading to moderate retinal changes without swelling in the macula. This stage is characterized by increased microaneurysms, dot-blot hemorrhages, hard exudates, and venous beading, but no significant macular edema. While vision may not be immediately affected, ongoing monitoring is essential to prevent progression to more severe stages.

Causes

High blood sugar levels over time damage the retinal blood vessels, leading to moderate nonproliferative diabetic retinopathy. Insulin resistance or insufficient insulin production in type 2 diabetes contributes to sustained hyperglycemia, which triggers vascular changes in the retina. Metabolic factors associated with diabetes, such as advanced glycation end products, also play a role in this ocular complication.

Risk Factors

  • Poorly controlled blood glucose levels.
  • Long duration of diabetes.
  • Hypertension and dyslipidemia.
  • Smoking.
  • Obesity and sedentary lifestyle.

Symptoms

  • Mild to moderate blurring or fluctuating vision in both eyes.
  • Presence of floaters or spots in the visual field.

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilated retinal imaging (e.g., fundus photography or optical coherence tomography) to assess retinal changes. Blood tests to evaluate glycemic control and other metabolic factors may also be performed. The bilateral nature of the condition is confirmed through examination of both eyes.

Treatment Options

Management focuses on optimizing blood glucose, blood pressure, and lipid levels to slow disease progression. Regular eye exams are recommended to monitor for changes. In some cases, laser therapy or anti-VEGF injections may be considered if progression occurs, though these are not typically needed at this stage.

Prognosis and Follow-Up

With proper glycemic control and regular monitoring, progression to severe retinopathy can be delayed. Follow-up eye exams are typically scheduled every 6 to 12 months, or more frequently if changes are detected. Early intervention is key to preserving vision.

Complications

If left unmanaged, moderate nonproliferative diabetic retinopathy may progress to severe nonproliferative or proliferative diabetic retinopathy, increasing the risk of vision loss. Macular edema, though not present here, can develop and further impair vision.

Lifestyle & Prevention

  • Maintain tight blood glucose control through diet, exercise, and medication.
  • Manage blood pressure and cholesterol levels.
  • Avoid smoking and limit alcohol intake.
  • Engage in regular physical activity and maintain a healthy weight.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, increased floaters, or vision loss in either eye. Regular eye exams are critical for early detection of progression.

Tips for Medical Coders

Document the bilateral nature of the condition clearly in the medical record. Ensure the absence of macular edema is noted, as this distinguishes the code from those with macular involvement. Use this code only when both eyes are affected and the retinopathy is moderate without macular edema.

Book a walkthrough

E11.3393 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.